Proxima Capital Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Proxima Capital Management’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$41K	Hold	77,624	–	–	0.19%	26
2020 Q2	$53K	Sell	77,624 -14,076	-15%	-$11.2K	0.27%	25
2020 Q1	$69K	Sell	91,700 -78,594	-46%	-$108K	0.43%	25
2019 Q4	$257K	Sell	170,294 -35,706	-17%	-$53.6K	0.77%	26
2019 Q3	$305K	Hold	206,000	–	–	0.47%	28
2019 Q2	$266K	Hold	206,000	–	–	0.36%	27
2019 Q1	$538K	Sell	206,000 -75,000	-27%	-$176K	0.59%	27
2018 Q4	$464K	Sell	281,000 -14,000	-5%	-$39.3K	0.44%	33
2018 Q3	$1.43M	Hold	295,000	–	–	0.95%	26
2018 Q2	$1.84M	Buy	295,000 +75,000	+34%	+$559K	1.09%	24
2018 Q1	$1.83M	Buy	220,000 +15,000	+7%	+$143K	1%	30
2017 Q4	$2.09M	Buy	+205,000	New	+$1.97M	1.21%	29

Other funds holding NEOS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Proxima Capital Management's NEOS Position: Q3 2020 in Review

Proxima Capital Management held its Neos Therapeutics, Inc (NEOS) position steady in Q3 2020 at 77,624 shares worth $41K. The position accounts for 0.19% of the portfolio, ranked #26.

Proxima Capital Management first reported a position in NEOS in Q4 2017 and has held it in 12 quarters since. The position peaked at $2.09M in Q4 2017. 41 funds tracked by Wall St. Rank hold NEOS as of Q3 2020.

Proxima Capital Management held 77,624 shares of Neos Therapeutics, Inc worth $41K as of Q3 2020.
Proxima Capital Management left its Neos Therapeutics, Inc share count unchanged in Q3 2020.
Neos Therapeutics, Inc made up 0.19% of Proxima Capital Management's portfolio in Q3 2020, its #26 holding.
Proxima Capital Management first reported a position in Neos Therapeutics, Inc in Q4 2017 and has held it in 12 quarters since.
Proxima Capital Management's Neos Therapeutics, Inc position peaked at $2.09M in Q4 2017.
41 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q3 2020.

Based on Proxima Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.